Kineta Rolls Out New Stock and Cash Incentive Plans
PremiumCompany AnnouncementsKineta Rolls Out New Stock and Cash Incentive Plans
7M ago
Kineta Reports Progress in KVA12123 Cancer Trial
Premium
Company Announcements
Kineta Reports Progress in KVA12123 Cancer Trial
7M ago
Kineta  presents data from Phase 1/2 VISTA-101 clinical trial at AACR
Premium
The Fly
Kineta presents data from Phase 1/2 VISTA-101 clinical trial at AACR
7M ago
Kineta to present new preclinical data on KVA12123
PremiumThe FlyKineta to present new preclinical data on KVA12123
9M ago
Kineta provides update on ongoing Phase 1/2 VISTA-101 trial of KVA12123
Premium
The Fly
Kineta provides update on ongoing Phase 1/2 VISTA-101 trial of KVA12123
10M ago
Kineta publishes preclinical data on KVA12123
Premium
The Fly
Kineta publishes preclinical data on KVA12123
11M ago
Kineta  announces $3M registered direct offering priced at $3.37 per share
PremiumThe FlyKineta announces $3M registered direct offering priced at $3.37 per share
1y ago
Kineta announces KVA12123 data from Phase 1/2 VISTA-101 trial
Premium
The Fly
Kineta announces KVA12123 data from Phase 1/2 VISTA-101 trial
1y ago
Kineta enters research agreement with Fred Hutchinson Cancer Center
Premium
The Fly
Kineta enters research agreement with Fred Hutchinson Cancer Center
1y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100